Internal Medicine, Hematology & Oncology · Lancaster, PA
NPI
1144454638
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2102 Harrisburg Pike
Lancaster, PA, 17601
Phone (717) 544-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
1,299 services
Medicare patients, 2024
402
Average age 74
Drug cost, 2024
$2.5M
1,769 prescriptions
Company payments, 2025
$95.8
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Srilatha B Hosur was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 539 times for 278 patients. In total Srilatha B Hosur billed 1,299 services in 19 codes, and Medicare paid $73K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 539 | 278 | $11.61 | $6,260 |
| 99214 Office E&M - Established | Office | 408 | 211 | $86.28 | $35K |
| 99215 Office E&M - Established | Office | 49 | 39 | $118.06 | $5,785 |
| 99213 Office E&M - Established | Office | 48 | 44 | $60.15 | $2,887 |
| 99205 Office E&M - New | Office | 46 | 46 | $157.21 | $7,232 |
| 99204 Office E&M - New | Office | 40 | 40 | $119.88 | $4,795 |
| 99223 Hospital E&M - Initial | Facility | 33 | 33 | $127.10 | $4,194 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 22 | $58.08 | $1,684 |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $98.73 | $2,271 |
| 99211 Office E&M - Established | Office | 23 | 23 | $16.48 | $379 |
| 99451 E&M - Miscellaneous | Office | 20 | 20 | $23.76 | $475 |
| 99231 Hospital E&M - Subsequent | Facility | 19 | 13 | $36.10 | $686 |
By year: 2022 $77K for 764 services; 2023 $72K for 778 services; 2024 $73K for 1,299 services.
Medicare prescription drug claims, 2024
In 2024, the drug Srilatha B Hosur prescribed most often to Medicare patients was Anastrozole, with 475 prescriptions and refills. In total Srilatha B Hosur wrote 1,769 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 475 | 1,063 | 141 | $9,125 |
| Tamoxifen Citrate Generic | 188 | 424 | 61 | $5,699 |
| Letrozole Generic | 139 | 307 | 37 | $3,230 |
| Ondansetron Hcl Generic | 74 | 74 | 48 | $543 |
| Olanzapine Generic | 62 | 64 | 30 | $377 |
| Exemestane Generic | 53 | 91 | 20 | $7,831 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 50 | 55 | 14 | $121 |
| Dexamethasone Generic | 44 | 47 | 18 | $380 |
| Loperamide Loperamide Hcl | 38 | 41 | 20 | $290 |
| Famotidine Generic | 34 | 34 | Under 11 | $105 |
| Acyclovir Generic | 34 | 42 | Under 11 | $358 |
| Kisqali Ribociclib Succinate | 34 | 34 | Under 11 | $476K |
| Gabapentin Generic | 31 | 31 | 13 | $119 |
| Ibrance Palbociclib | 28 | 28 | Under 11 | $427K |
| Allopurinol Generic | 26 | 35 | Under 11 | $162 |
Brand drugs: - claims; generic drugs: 1,573 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Srilatha B Hosur $95.8 ($95.8 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $68.49.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.